Coinheritance of X-linked agammaglobulinemia and grow;h hormone defici
ency (XLA/GHD) has been classified as an independent primary immune de
ficiency. We evaluated the pattern of growth and endocrine function in
seven XLA subjects (ages 10.9-20.1 years); four belonged to two diffe
rent XLA pedigrees and three represented sporadic XLA cases. Three had
reached adulthood (final stature 176.0, 173.5 and 165.0 cm, respectiv
ely) and their retrospective growth showed delay in growth and puberty
during adolescence. In the other four subjects, growth hormone produc
tion was measured by growth hormone pharmacological stimulation tests
(clonidine, arginine): three of four patients had insufficient growth
hormone responses (peak growth hormone <10 mu g/l); all three had dela
yed puberty; their growth hormone responses increased after ''priming'
' with testosterone, reaching values > 10 mu g/l in two of them and al
lowing diagnosis of ''true'' growth hormone deficiency in the third. T
he fourth was a normally growing subject who showed a normal growth ho
rmone response both before and after testosterone priming. Six out of
the seven subjects showed a growth pattern consistent with delay in gr
owth and puberty. Our results suggest that true XLA/GHD is rarer than
previously supposed and that subnormal responses to growth hormone sti
mulation tests may be found without sex steroid priming of the test in
adolescence. The most probable growth pattern in XLA appears to be de
lay in growth and puberty, as has already been described for other chr
onic diseases.